| Journal | Cannabis and cannabinoid research |
| Study Type | Systematic Review |
| Population | Human participants |
Administrative health data drives policy decisions, insurance coverage, and resource allocation for cannabis use disorder treatment. Without standardized, validated case definitions, we’re making clinical and policy decisions based on inconsistent data that may misrepresent the true prevalence and treatment needs of CUD patients.
This systematic review of 56 studies reveals significant inconsistencies in how cannabis use disorder is identified in administrative health databases. Most studies used ICD-9 or ICD-10 diagnostic codes with varying operational definitions, observation windows, and coding strategies across different jurisdictions. The lack of validated case definitions creates substantial uncertainty about the accuracy of CUD prevalence estimates and treatment outcome data derived from administrative sources. These inconsistencies undermine the reliability of epidemiologic surveillance and health services research that informs clinical guidelines and policy decisions.
“This highlights a fundamental problem I see daily – our diagnostic frameworks for cannabis haven’t kept pace with evolving use patterns and legal landscapes. The administrative data we rely on for population health insights may be systematically missing or misclassifying patients who would benefit from intervention.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
How is Cannabis Use Disorder currently identified in electronic health records?
Most healthcare systems rely on ICD-9 or ICD-10 diagnostic codes using a “one-or-more-code rule” to identify CUD cases. However, this systematic review of 56 studies found significant variation in coding practices across jurisdictions, coding frameworks, and observation windows, which may lead to inconsistent identification of patients with CUD.
How accurate are administrative health data for identifying Cannabis Use Disorder?
The systematic review revealed that no standardized validation approaches exist for CUD case definitions in administrative health data. This lack of validation means clinicians cannot be certain about the accuracy of CUD prevalence estimates or patient identification when relying solely on administrative coding data.
Why does variation in Cannabis Use Disorder coding matter for patient care?
Inconsistent coding practices can undermine the comparability and accuracy of CUD estimates across different healthcare systems and regions. This variation may lead to missed diagnoses, inappropriate resource allocation, and difficulties in tracking treatment outcomes or conducting meaningful research comparisons.
What are the implications for Cannabis Use Disorder surveillance and policy?
Reliable case definitions are essential for epidemiologic surveillance, health services research, and policy evaluation regarding cannabis use disorders. The current lack of standardized, validated coding approaches may compromise public health monitoring efforts and evidence-based policy development as cannabis legalization expands.
How can healthcare systems improve Cannabis Use Disorder identification and tracking?
Healthcare systems need to develop and implement standardized, validated case definitions for CUD in administrative health data. This should include consistent coding practices, defined observation windows, and validation studies to ensure accurate identification of patients with cannabis use disorders for both clinical care and research purposes.
